| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/23/2008 | CN101166547A MRI contrast agents comprising cest active paramagnetic complexes |
| 04/23/2008 | CN101166537A Ex vivo gene expression in whole blood as a model of assessment of individual variation to dietary supplements |
| 04/23/2008 | CN100382847C Ligand compound for image diagnosis and its preparing method and compound for image diagnosis and its intermediate preparation |
| 04/23/2008 | CN100382846C Method for improved imaging and photodynamic therapy |
| 04/22/2008 | US7361684 Screening of compounds for treatment of atherosclerosis and heart attack |
| 04/22/2008 | US7361477 Methods and compositions for inhibiting cellulolytic symbionts |
| 04/22/2008 | US7361336 Administering antibody or a fragment thereof that binds to a human homolog of frizzled, to inhibit the proliferation of cancer cells |
| 04/22/2008 | CA2319433C Targeted delivery of biologically active media |
| 04/17/2008 | WO2008046045A1 Drug biovailability screens |
| 04/17/2008 | WO2008045604A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/17/2008 | WO2008044443A1 Gadolinium compound and contrast medium for mri |
| 04/17/2008 | WO2008043561A2 Influenza targets |
| 04/17/2008 | WO2007057182B1 Fluorescent nanoparticles |
| 04/17/2008 | US20080090912 Compositions containing prodrugs of florfenicol and methods of use |
| 04/17/2008 | US20080089847 Radioactive18F labelled CF3(CF2)nR1 ( R1= acid, ester, amine, amide, halogen, ether, nitrile, perhaloalkyl etc.); carrier is formulated as an injectable fluid, aerosol, cream, gel, pill, capsule, or a syrup; assessing cell or tissue distribution using positron emission tomography instrument |
| 04/17/2008 | US20080089845 optimizing therapeutic efficacy for treatment of anxiety, depression, pain, or a metabolic disorder by increasing or decreasing a dose of a fatty amide ( oleoylethanolamide or palmitoylethanolamide) hydrolase inhibitor according to a patient's fatty amide levels by administering a carbamate derivative |
| 04/17/2008 | US20080089842 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide |
| 04/17/2008 | US20080089841 Continuous Vessel-Selective Spin Labeling |
| 04/17/2008 | US20080089840 monofilament comprising an absorbable polyether-ester; polyether glycol end-grafted with at least one cyclic monomer selected from the group consisting of l-lactide, glycolide, p-dioxanone, trimethylenecarbonate, caprolactone, 1,5-dioxepan-2-one and a morpholinedione; 20% increase in cross-sectional area |
| 04/17/2008 | US20080089839 Preparation of Stable High Concentration Coloidal Metal Particulate System |
| 04/17/2008 | US20080089838 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer |
| 04/17/2008 | US20080089836 superparamagnetic nanoparticles of iron coated with bilayer of molecules:(a) layer of oleic acid in direct contact with the iron particles; (b) a layer of Tween"; bilayer of surface binding molecules and amphiphatic molecules; self-assembles; solubilizing; reducing toxicity; gold in MRI and tomography |
| 04/17/2008 | CA2664826A1 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 04/16/2008 | EP1911471A1 Agent for visualizing vitreous body |
| 04/16/2008 | EP1910575A2 Immunohistochemistry detection method |
| 04/16/2008 | EP1909852A2 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases |
| 04/16/2008 | EP1909851A2 Method, dye and medicament for staining the internal limiting memebrane, the vitreous and/or the capsule of an eye |
| 04/16/2008 | EP1758616B1 Use in the medical, diagnostic and phlebological field of a mixture of sterile and physiologically acceptable gases |
| 04/16/2008 | EP1467771B1 Mycobacterial vaccine |
| 04/16/2008 | EP1250091B1 Hydrophilic cyanine dyes |
| 04/16/2008 | CN201046114Y A new type spinal cord stroking apparatus |
| 04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
| 04/15/2008 | US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology |
| 04/15/2008 | US7358054 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/15/2008 | US7357916 Method for creating a uniform vascular wound in zebrafish or zebrafish larva |
| 04/15/2008 | US7357915 Method of imaging cell death in vivo |
| 04/15/2008 | CA2313164C Skin test for schizophrenia |
| 04/15/2008 | CA2170379C Photosensitizers |
| 04/10/2008 | WO2008043101A2 Intraoperative imaging of hepatobiliary structures |
| 04/10/2008 | WO2007127372A3 Genetic adjuvants for viral vaccines |
| 04/10/2008 | WO2007066119A3 Novel imaging agents for fibrosis |
| 04/10/2008 | US20080085245 with a detectable marker such as a food dye; presence of the anesthetic agent on the wound is indicated by the marker; anaesthetizing open wounds of animals, particularly those caused by husbandry procedures |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | US20080085241 highly selective; tumor-specific binding proteins; amino acid sequence; nucleic acid molecule; recombinant expression vector; host cell; cancer diagnosis; identify only those markers recognized by the human immune system as sufficiently foreign to trigger the production of antibodies; antigen is CD98hc |
| 04/10/2008 | US20080085238 to detect amyloid deposits prior to aggregation into plaques; labeled bifunctional compound binds to target protein and to chaperone protein; Alzheimer's; 1-[4-(carboxymethoxy)phenyl]-3-(3,4-dimethoxy-phenyl)-1-propanyl-1-(3,3-dimethyl-1,2-dioxopentyl)-2-piperidinecarboxylate isomers bind differently |
| 04/09/2008 | EP1908780A1 Novel chimeric proteins and methods for using the same |
| 04/09/2008 | EP1908479A2 Anti-p53 Antibodies |
| 04/09/2008 | EP1907018A2 Diagnosis and prognosis of diabetes |
| 04/09/2008 | EP1907017A2 Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| 04/09/2008 | EP1906990A1 Anticoagulation agent and uses thereof |
| 04/09/2008 | EP1156833B1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 04/09/2008 | EP0693924B2 Methods for (in vivo) delivery of biologics and compositions useful therefor |
| 04/09/2008 | CN101160403A Molecules for transporting a compound across the blood-brain barrier |
| 04/09/2008 | CN100379456C Preparation for the prophylaxis of restenosis |
| 04/08/2008 | US7355015 Matriptase, a serine protease and its applications |
| 04/08/2008 | US7354894 Administering epidermal growth factor receptor antagonist; blocking with monoclonal antibody, a kinase inhibitor, a metalloproteinase inhibitor; treating nasal polyps, chronic obstructive pulmonary disease |
| 04/08/2008 | US7354568 Magnetic resonance imaging agents for the detection of physiological agents |
| 04/08/2008 | CA2304819C Perforated microparticles and methods of use |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008017721A3 Method of covering self-assembled metal or inorganic monolayer surfaces of gem-bisphosphonic compounds and uses thereof |
| 04/03/2008 | WO2007047668A3 Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells |
| 04/03/2008 | US20080082048 Determining an injection region in a heterogeneous body structure |
| 04/03/2008 | US20080081021 Manganese-enhanced magnetic resonance imaging of neurons using electrical stimulation |
| 04/03/2008 | US20080081020 used to disinfect operative surgical sites and medical devices; changes color upon drying to indicate when the solution has completely dried; antimicrobial agent, pH adjusters (acid, a base, a pH buffer), and a color-change pH indicator |
| 04/03/2008 | US20080081019 Marker For Tardive Dyskinesia |
| 04/02/2008 | EP1905357A1 Method of imaging cell death in vivo |
| 04/02/2008 | EP1905309A1 Uses of oil bodies |
| 04/02/2008 | EP1904831A1 Device and method for determining the concentration of a substance |
| 04/02/2008 | EP1904463A2 Complexes containing perfluoroalkyl, method for the production and use thereof |
| 04/02/2008 | EP1904460A1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 04/02/2008 | EP1904183A2 Imaging and therapeutic method using monocytes |
| 04/02/2008 | EP1904081A2 Compositions and methods to control angiogenesis with cupredoxins |
| 04/02/2008 | EP1904064A2 Omeprazole form b |
| 04/02/2008 | EP1383542B1 In vivo method for measuring binding of chemical actives to skin or specific constituents of skin |
| 04/02/2008 | CN201042522Y Acetowhite detecting plaster strip |
| 04/02/2008 | CN101155600A Radiotherapy enhancer |
| 04/01/2008 | US7351874 Transgenic animals for use in the treatment of nervous system disorders |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351542 Methods of modulating tubulin deacetylase activity |
| 04/01/2008 | US7351408 Glycoconjugates and methods |
| 04/01/2008 | US7351401 Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
| 04/01/2008 | US7351389 Aminocarboxylate ligands having substituted aromatic amide moieties |
| 03/27/2008 | WO2008036792A2 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 03/27/2008 | WO2008036524A1 Fluorescent chemical sensor |
| 03/27/2008 | WO2008035069A1 Multimeric particles |
| 03/27/2008 | WO2008034911A1 New bio-compatible polymer materials, method for producing the same and uses thereof, particularly in medical magnetic-resonance imaging |
| 03/27/2008 | WO2008034621A2 Nucleotide phosphorylase for the prophylaxis, treatment or diagnosis of acute lung injury (ali) |
| 03/27/2008 | WO2008012785A3 A probe for cellular oxygen |
| 03/27/2008 | WO2008003524A3 Delivery of contrasting agents for magnetic resonance imaging |
| 03/27/2008 | WO2008000070B1 Glycyrrhetinic acid derivatives |
| 03/27/2008 | WO2007119098A3 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity |
| 03/27/2008 | US20080075667 Nanoparticles, nanocapsules and nanogels |
| 03/27/2008 | US20080075665 Methods of identifying xenohormetic phenotypes and agents |
| 03/27/2008 | US20080075663 Mouse Model of Chronic Heart Failure and Coronary Atherosclerosis Regression |
| 03/27/2008 | US20080075661 Imaging agent; a detectable label linked to glucose linked to an azide, alkyne or phosphine; azide, phosphine or alkyne labelled analogues of traditional building blocks can easily be incorporated into metabolic pathways |
| 03/27/2008 | US20080075659 Determining the percentage of monoclonal, chimerized, murine or humanized antibody greater than 90 percent using excess amount of CD66 antigen, and the percentage of immunoreactive antibody that binds specifically to CD66 |
| 03/27/2008 | DE102007043834A1 Histofluoreszierende Farbstoffzusammensetzung für die Endoskopie Histofluoreszierende dye composition for endoscopy |
| 03/27/2008 | CA2662977A1 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 03/26/2008 | EP1901782A2 Method for dissolution of gases with short-lived physical properties in a liquid |